Back to UBS Group AG UBS Group AG

VVOSVVOS
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in VIVOS THERAPEUTICS INC

UBS Group AG holds 39,154 shares of VVOS (VIVOS THERAPEUTICS INC), worth $17,815 as of 2026-Q2. The position was increased (+254.5% shares).

Current Value

$17,815

Current Shares

39,154

Total Value Change

+$17,611

Total Shares Change

+39,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
39,154
+254.5%
$17,8150.0%$0.46
20
2026-Q1
Decreased
11,046
-12.9%
$13,0350.0%$1.35
0
2025-Q4
Increased
12,677
+123x
$25,7340.0%$2.06
21
2025-Q3
Decreased
102
-99.9%
$3160.0%$3.13
0
2025-Q2
Increased
142,801
+7499.8%
$451,2510.0%$3.28
39
2025-Q1
Increased
1,879
+383.0%
$5,3550.0%$3.11
17
2024-Q4
Increased
389
+398.7%
$1,6690.0%$4.44
12
2024-Q3
New
78
-
$2040.0%$2.70
17

Other major holders of VVOS: Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used